menu
    • menu

    Company profile for Corcept Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    we are leading the discovery and development of drugs that modulate the effects of cortisol Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998. C...
    we are leading the discovery and development of drugs that modulate the effects of cortisol Cortisol dysregulation plays an important role in a variety of endocrine, metabolic, oncologic, psychiatric, and ophthalmologic diseases. Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998. Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Corcept TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    149 Commonwealth Drive Menlo Park, CA 94025
    Telephone
    Telephone
    650-327-3270
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.corcept.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/corcept-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Corcept Therapeutics Unveils Q3 Financials Result
    Corcept Therapeutics Unveils Q3 Financials Result

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104775200/en/Corcept-Therapeutics-Announces-Third-Quarter-Financial-Results-Oncology-Development-Programs-and-Provides-Corporate-Update

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Corcept Therapeutics To Report Q3 Financials, Update And Host
    Corcept Therapeutics To Report Q3 Financials, Update And Host

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028383789/en/Corcept-Therapeutics-to-Announce-Third-Quarter-Financial-Results-Provide-Corporate-Update-and-Host-Conference-Call

    BUSINESSWIRE
    28 Oct 2025
    Share Share
    Corcept’s Relacorilant Benefits PARPi-Treated Ovarian Cancer
    Corcept’s Relacorilant Benefits PARPi-Treated Ovarian Cancer

    19 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251019109551/en/Corcept-Presents-ESMO-2025-Late-Breaker-Relacorilant-Demonstrates-Benefit-in-Patients-with-Platinum-Resistant-Ovarian-Cancer-with-Prior-PARP-Inhibitor-Treatment

    BUSINESSWIRE
    19 Oct 2025
    Share Share
    Corcept Seeks EMA Approval For Relacorilant
    Corcept Seeks EMA Approval For Relacorilant

    14 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251014154513/en/Corcept-Submits-Marketing-Authorization-Application-to-European-Medicines-Agency-for-Relacorilant-as-a-Treatment-for-Patients-with-Platinum-Resistant-Ovarian-Cancer

    BUSINESSWIRE
    14 Oct 2025
    Share Share
    Curant Rare Partners Corcept Therapeutics In Pharmacy Deal
    Curant Rare Partners Corcept Therapeutics In Pharmacy Deal

    01 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251001096136/en/Curant-Rare-Announces-Pharmacy-Partnership-with-Corcept-Therapeutics

    BUSINESSWIRE
    01 Oct 2025
    Share Share
    Corcept Shares ROSELLA Trial Data in Ovarian Cancer at ESMO
    Corcept Shares ROSELLA Trial Data in Ovarian Cancer at ESMO

    22 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250922541539/en/Corcept-to-Present-New-Late-Breaking-Data-From-Pivotal-ROSELLA-Trial-of-Relacorilant-in-Platinum-Resistant-Ovarian-Cancer-at-ESMO-2025

    BUSINESSWIRE
    22 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search